Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 10/20 | 0.74 |
| ▸ | PGR | P06401 | 6/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.74 |
| ▸ | HIF1A | Q16665 | 4/20 | 0.74 |
| ▸ | LMNA | P02545 | 3/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.74 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.74 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.74 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.74 |
| ▸ | IL5 | P05113 | 1/20 | 0.74 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.74 |
| ▸ | AR | P10275 | 1/20 | 0.74 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.74 |
| ▸ | MMP9 | P14780 | 1/20 | 0.74 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.74 |
| ▸ | THPO | P40225 | 1/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.74 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.74 |
| ▸ | BLM | P54132 | 1/20 | 0.74 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14001451 | 1.00 | NR3C1 (0.74) | NR3C1PGRCYP3A4HIF1ALMNA | |
| SCHEMBL13816836 | 0.91 | NR3C1 (0.75) | NR3C1PGRCYP3A4HIF1ALMNA | |
| SCHEMBL21152812 | 0.91 | NR3C1 (0.74) | NR3C1PGRCYP3A4HIF1ALMNA | |
| Budesonide SCHEMBL4447873 | 0.90 | NR3C1 (0.82) | NR3C1PGRCYP3A4HIF1ALMNA | |
| Dexbudesonide SCHEMBL4447872 | 0.90 | NR3C1 (0.82) | NR3C1PGRCYP3A4HIF1ALMNA | |
| SCHEMBL5396842 | 0.90 | NR3C1 (0.81) | NR3C1PGRCYP3A4HIF1ALMNA | |
| SCHEMBL15507523 | 0.90 | NR3C1 (0.72) | NR3C1PGRCYP3A4HIF1ALMNA | |
| SCHEMBL21152548 | 0.90 | NR3C1 (0.74) | NR3C1PGRCYP3A4HIF1ALMNA | |
| SCHEMBL21153649 | 0.90 | NR3C1 (0.74) | NR3C1PGRCYP3A4HIF1ALMNA | |
| SCHEMBL7735898 | 0.89 | ALDH1A1 (0.84) | NR3C1PGRCYP3A4HIF1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8710036-B2 | Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists | SUNOVION PHARMACEUTICALS INC. (US) | 2014-04-29 | — | — | US | disclosed |
| US-8710036-B2 | Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists | SUNOVION PHARMACEUTICALS INC. (US) | 2014-04-29 | — | — | US | disclosed |
| US-20130244988-A1 | CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS | SUNOVION PHARMACEUTICALS INC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-20130244988-A1 | CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS | SUNOVION PHARMACEUTICALS INC. (US) | 2013-09-19 | — | — | US | disclosed |
| US-8445470-B2 | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists | SUNOVION PHARMACEUTICALS INC. (US) | 2013-05-21 | — | — | US | disclosed |
| US-20090163456-A1 | CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS | SEPRACOR INC. (US) | 2009-06-25 | — | — | US | disclosed |
| US-20090163456-A1 | CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS | SEPRACOR INC. (US) | 2009-06-25 | — | — | US | disclosed |
| US-7468362-B2 | Carbonate and carbamate modified forms of glucocorticoids in combination with β2 adrenergic agonists | SEPRACOR INC. (US) | 2008-12-23 | — | — | US | disclosed |
| US-20080103119-A1 | CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS | SEPRACOR INC. (US) | 2008-05-01 | — | — | US | disclosed |
| US-7253156-B2 | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists | SEPRACOR INC. (US) | 2007-08-07 | — | — | US | disclosed |
| US-7253156-B2 | Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists | SEPRACOR INC. (US) | 2007-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103119-A1 | CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS | ADRB2, ADRA2C, NR3C2 | NR3C1 12/4885PGR 449/4885CYP3A4 698/4885 |
| US-20130244988-A1 | CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS | ADRB2, CHRM2, NR3C2 | NR3C1 10/4885PGR 443/4885CYP3A4 698/4885 |
| US-20090163456-A1 | CARBONATE AND CARBAMATE MODIFIED FORMS OF GLUCOCORTICOIDS IN COMBINATION WITH B2 ADRENERGIC AGONISTS | ADRB2, CHRM2, NR3C2 | NR3C1 10/4885PGR 443/4885CYP3A4 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.